Medication burden trajectories during hospitalization in older patients with hematological malignancies

Abstract

Among patients with cancer, and particularly in the inpatient setting, patients with hematological malignancies are exposed to more complex medication regimens resulting from intensive supportive care combining chemotherapeutic, immunosuppressive, and antimicrobial agents and longer length of stay. Moreover, with increasing age, the prevalence of comorbidities with chronic medicationuse increases the medication burden. Hence, hospitalized older patients with hematological malignancies may represent a particularly relevant population for investigating longitudinal medication trajectories.

Social Inequalities, Geographical Accessibility to Care, and Excess Mortality for Patients With Hematological Malignancies in France: Results From French Cancer Registries
J. Gardy, X. Troussard, M. Maynadié +17
Hematological Oncology18 Sep 2026Peer-reviewedLicence not statedFull textGeneral biology OncologyHAL
Genomic characterization of carbapenem-resistant organisms from pediatric patients with hematological malignancies and genomic comparison of infection versus intestinal colonizing strains
Chao Fang, Zheng Zhou, Jianping Li +7
Microbiology Spectrum2 Oct 2026Peer-reviewedCC BY 4.0Full textMicrobiologyDOAJPMC
Factors associated with treatment resumption and long-term outcomes after ICU discharge in patients with hematological malignancies
Ondine Messéant, Mathilde Guégan, Benoit Painvin +6
Annals of Intensive Care19 Oct 2026Peer-reviewedCC BY 4.0Full textGeneral biology OncologyHAL
Central Nervous System Toxoplasmosis Beyond HIV in Patients with Hematologic Malignancies: A Contemporary Narrative Review and Illustrative Case Synthesis
Aleksandra Łanocha, Oliwia Pawelec-Pęciak, Karolina Kot +3
International Journal of Molecular Sciences1 Oct 2026Peer-reviewedCC BY 4.0Full textMicrobiologyCrossrefEurope PMC
Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone
David Misdrahi, Franck Baylé, Arnaud Tessier +1
Patient Preference and Adherence15 Oct 2026Peer-reviewedCC BY-NCFull text18 citedNeuroscience Psychiatry & mental healthHAL

Cite

BibTeX RIS

BibTeX

@article{roudeix2026medication,
  title = {{Medication burden trajectories during hospitalization in older patients with hematological malignancies}},
  author = {Jeanne Roudeix and David Malnoë and Mathilde Bories and Pascal Le Corre},
  journal = {Journal of Geriatric Oncology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jgo.2026.104384},
  url = {https://hal.science/hal-05779205v1},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Medication burden trajectories during hospitalization in older patients with hematological malignancies
AU  - Jeanne Roudeix
AU  - David Malnoë
AU  - Mathilde Bories
AU  - Pascal Le Corre
PY  - 2026
DA  - 2026/10/05
JO  - Journal of Geriatric Oncology
DO  - 10.1016/j.jgo.2026.104384
UR  - https://hal.science/hal-05779205v1
AB  - Among patients with cancer, and particularly in the inpatient setting, patients with hematological malignancies are exposed to more complex medication regimens resulting from intensive supportive care combining chemotherapeutic, immunosuppressive, and antimicrobial agents and longer length of stay. Moreover, with increasing age, the prevalence of comorbidities with chronic medicationuse increases the medication burden. Hence, hospitalized older patients with hematological malignancies may represent a particularly relevant population for investigating longitudinal medication trajectories.
SN  - 1879-4068
SN  - 1879-4076
ER  -

Abstract

Related

Cite